Table 2:
Parameter | POTS | Control | ||
---|---|---|---|---|
Supine | HUT | Supine | HUT | |
Tilt Table Test | ||||
HR, bpm | 78±3 | 122±5* | 66±3 | 85±3 |
Systolic BP, mmHg | 103±2 | 107±3 | 107±2.5 | 110±2.5 |
Diastolic BP, mmHg | 66±1.5 | 71±3 | 69±2.5 | 73±2 |
iMSNA, burst/min | 12±1.5* | 38±3 | 20±2 | 42±5 |
iMSNA, burst/100b | 14.3±2* | 29±3 | 31±3 | 41±4 |
iMSNA, burst/100b | 2.5±0.4* | 12.5±2.5 | 5±0.5 | 12±2 |
Norepinephrine, pg/ml | 164±14 | 503±55 | 209±32 | 480±50 |
DHPG / NE ratio | 7.5±1 | 3.3±0.4 | 6.9±0.6 | 3.4±0.3 |
Epinephrine, pg/ml | 22±3 | 80±10 | 14±3 | 110±20 |
Autonomic Function Test Sympathetic Response |
||||
Δ BP Hyperventilation, mmHg | −8±3 | −9±3 | ||
Δ BP Hand Grip, mmHg | 12±2.5 | 7.5±1.5 | ||
Δ BP Cold Pressor Test, mmHg | 20±4 | 17±5 | ||
Δ BP Valsalva Phase 2, mmHg | −32±5.8* | −14±4 | ||
Δ BP Valsalva Phase 4, mmHg | 32±3 | 25±5 | ||
Vagal Response | ||||
Deep Breathing RSA Ratio | 1.3±0.01* | 1.6±0.05 | ||
Valsalva Ratio | 2.0±0.1 | 1.9±0.1 |
HR, Heart Rate, BP, Blood Pressure, iMSNA, Integrated Muscle Sympathetic Activity, DHPG, Dihydroxyphenylglycol, NE, Norepinephrine, RSA, Respiratory Sinus Arrhythmia
significant group differences between POTS and controls, p<0.05